D-Wave (QBTS) Q1 2026 Earnings Transcript

D-Wave reported Q1 revenue of $2.9 million, down 81% year over year, but bookings surged to $33.4 million, up 1,994%, driven by a $20 million system sale and a $10 million enterprise license. Management raised its system sales outlook to at least two deliveries in 2026 and highlighted a new dual-platform strategy after the Quantum Circuits acquisition, with cash and marketable securities at $588.4 million. The quarter was loss-making, with net loss widening to $18.4 million and operating expenses up 125%, but the backlog and pipeline point to stronger future commercial activity.

Analysis

QBTS is morphing from a single-product story into a capital-allocation story, and that matters more than the headline revenue print. The bookings surge and larger backlog improve the probability-weighted revenue base, but the mix implies lumpy recognition and a longer-duration conversion cycle, so the market should treat this less like a clean SaaS re-rate and more like a hardware-plus-software project business with optionality attached. The key second-order effect is that a richer pipeline and larger system deals can mask underlying burn acceleration for several quarters, which means upside in the stock is likely to come from order flow surprise, not from near-term margin recovery.

The acquisition creates an interesting competitive asymmetry: D-Wave is trying to own both the “today” optimization market and the “tomorrow” gate-model market, which expands narrative TAM, but also widens execution risk. If the dual-platform pitch gains credibility, it could pull budget share from early-stage quantum peers and force larger incumbents to justify why they are not offering a similar hybrid roadmap. But the real winner may be the ecosystem around it — GPU, cryo-control, and quantum software tooling vendors — because a broader platform strategy increases the number of integration points and the amount of experimentation customers will fund before true utility emerges.

The contrarian read is that the market may be underestimating how much of the current enthusiasm is financed by a few large, non-recurring transactions. The stock can continue to squeeze higher if Investor Day validates the roadmap and if another system deal lands, but the setup is fragile: any miss on a second-half delivery schedule, or evidence that the pipeline converts slower than implied, would compress multiple quickly. Conversely, if commercial AI/blockchain use cases stay in pilot mode through year-end, the narrative premium likely fades even if bookings stay elevated.

For now, the trade is about asymmetry: good news can move the stock hard because expectations are still anchored to a small installed base, while bad news mostly shows up as timing risk. That makes QBTS a high-beta event-driven long rather than a fundamental compounder in the near term. The cleanest setup is to own optionality into the next catalyst while respecting that revenue quality is still not yet self-funding.

Key Decisions for Investors

• Go long QBTS on pullbacks into Investor Day (June 1) using a small core + call spread structure; upside comes from roadmap validation and any incremental system-sale announcement, while downside is capped by current cash runway but elevated by execution risk.
• Buy QBTS Jan-2027 call spreads or long-dated calls instead of common; this captures the 12-24 month commercialization window for gate-model milestones and system conversions without overpaying for near-term revenue volatility.
• Pair trade: long QBTS / short a basket of early-stage quantum peers with weaker commercial proof points; QBTS has the stronger bookings backdrop and balance sheet, but the pair should be sized for event risk around roadmap credibility.
• If already long NVDA, use QBTS as a thematic satellite only, not a substitute; D-Wave’s near-term driver is customer adoption and system delivery, while NVDA remains the safer AI infrastructure expression.
• Take profits into any post-earnings gap-up above prior resistance unless there is a confirmed second commercial system win; the stock can re-rate fast, but the risk/reward deteriorates sharply once narrative momentum outruns delivery cadence.